SL-28
N/A
Report date: 2026/01/15 20:00:17
Base Information
Drug NameSL-28
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[20]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSecond Life Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesSecond Life Therapeutics Inc
Inactive CompaniesN/A
Active Indications +[19]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A